EDWARD MARK SCOLNICK

Summary

Affiliation: Massachusetts Institute of Technology
Country: USA

Publications

  1. ncbi Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?
    Edward M Scolnick
    Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge 02139, USA
    Harv Rev Psychiatry 14:64-77. 2006
  2. ncbi Program to improve cognitive functioning in patients with schizophrenia: reflections
    Edward Scolnick
    Psychiatric Disease Initiative, Broad Institute, USA
    Schizophr Res 72:75-7. 2004
  3. ncbi Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations
    Edward M Scolnick
    Psychiatric Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02139, USA
    Biol Psychiatry 59:1039-45. 2006
  4. ncbi Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions
    Soumya Raychaudhuri
    Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America
    PLoS Genet 5:e1000534. 2009
  5. ncbi Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia
    Mousumi Mutsuddi
    Psychiatric Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA
    Am J Hum Genet 79:903-9. 2006

Collaborators

Detail Information

Publications5

  1. ncbi Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?
    Edward M Scolnick
    Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge 02139, USA
    Harv Rev Psychiatry 14:64-77. 2006
    ..The model outlines experimental approaches that may, in the future, shed more light on its validity...
  2. ncbi Program to improve cognitive functioning in patients with schizophrenia: reflections
    Edward Scolnick
    Psychiatric Disease Initiative, Broad Institute, USA
    Schizophr Res 72:75-7. 2004
    ..Significant credit is due Dr. Steven Hyman and his colleagues for stimulating this bold initiative. Many problems remain to be solved to accomplish the goal. This article articulates a few such problems...
  3. ncbi Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations
    Edward M Scolnick
    Psychiatric Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02139, USA
    Biol Psychiatry 59:1039-45. 2006
    ..An approach to identifying risk genes based upon association studies starting with very large sample sizes based upon currently available diagnoses of bipolar disorder and schizophrenia is advocated...
  4. ncbi Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions
    Soumya Raychaudhuri
    Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America
    PLoS Genet 5:e1000534. 2009
    ..An online version of this method is available for public use (http://www.broad.mit.edu/mpg/grail/)...
  5. ncbi Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia
    Mousumi Mutsuddi
    Psychiatric Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA
    Am J Hum Genet 79:903-9. 2006
    ..Evidence of association is, at present, equivocal and unsatisfactory. The new dense map of the region may be valuable in more-comprehensive follow-up studies...